About Illumina, Inc.

Illumina, Inc. (NASDAQ: ILMN) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $42.7B. Its Maz Rating is 4.45 out of 5 (A, Strong Buy), ranked against the other companies in its sector.

Factor scores: Valuation 1.21, Growth 2.60, Profitability 4.94, Financial Health 3.48, Momentum 4.82 (as of 2026-10-16).

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

CEO

Jacob Thaysen

Employees

8,600

IPO date

2000-07-28